Impact of long-term ethanol consumption on CYP1A2 activity

被引:22
作者
Rizzo, N
Hispard, E
Dolbeault, S
Dally, S
Leverge, R
Girre, C
机构
[1] HOP FERNAND WIDAL,CLIN TOXICOL,F-75010 PARIS,FRANCE
[2] HOP LARIBOISIERE,PARIS,FRANCE
关键词
D O I
10.1016/S0009-9236(97)90045-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ethanol is a well-known inducer of CYP2E1; whether or not it is an inducer of other cytochromes has not been investigated systematically, The aim of our study was to evaluate the impact of ethanol consumption on the activity of CYP1A2, which has been shown to be influenced by drugs (inhibited or induced). We evaluated CYP1A2 activity by the ratio of the molar urinary concentrations of the three end products of paraxanthine demethylation of caffeine to the molar concentration of a paraxanthine 8-hydroxylation product, This urinary metabolite ratio has previously been shown to correlate with caffeine clearance. The caffeine metabolites were measured in urine collected during the 3 hours after oral administration of 200 mg caffeine. The caffeine test was performed in 12 smokers (>25 cigarettes/day) and 12 nonsmokers, all of whom were alcoholic inpatients (daily intake > 100 gm absolute ethanol), within the first 3 days of their hospital stay and after 14 days of abstinence from ethanol. In alcoholic patients who were smokers the molar urinary concentration ratio was 3.14 +/- 0.97 before withdrawal and 4.01 +/- 0.92 after 14 days of abstinence from ethanol. In contrast, in alcoholic patients who were nonsmokers it was 2.62 +/- 0.95 and 2.18 +/- 0.96 before and after withdrawal, respectively, In volunteers who were smokers the molar urinary concentration ratio was 5.02 +/- 1.51, whereas in volunteers who were nonsmokers it was 3.22 +/- 1.46. Our results confirm the well-known induction of CYP1A2 activity by tobacco smoking and show that this induction is masked by long-term ethanol consumption.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 22 条
[1]  
BERTHOU F, 1991, DRUG METAB DISPOS, V19, P561
[2]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[3]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[4]  
CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
[5]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[6]  
CATTEAU A, 1995, EUR J CLIN PHARMACOL, V47, P423
[7]  
CONNEY AH, 1976, CLIN PHARMACOL THER, V20, P633
[8]  
DESCOTES J, 1979, THERAPIE, V34, P619
[9]   INFLUENCE OF ALCOHOL AND CAFFEINE CONSUMPTION ON CAFFEINE ELIMINATION [J].
GEORGE, J ;
MURPHY, T ;
ROBERTS, R ;
COOKSLEY, WGE ;
HALLIDAY, JW ;
POWELL, LW .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1986, 13 (10) :731-736
[10]   ASSESSMENT OF CYTOCHROME P4502E1 INDUCTION IN ALCOHOLIC PATIENTS BY CHLORZOXAZONE PHARMACOKINETICS [J].
GIRRE, C ;
LUCAS, D ;
HISPARD, E ;
MENEZ, C ;
DALLY, S ;
MENEZ, JF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1503-1508